| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5947864 | Atherosclerosis | 2013 | 8 Pages |
Abstract
TCZ adversely impacts on both LDLc as well as fasting and postprandial TG in patients with RA. The changes in hepatic LDLr expression following TCZ imply that adverse lipid changes may be a direct hepatic effect of TCZ. The net effect of TCZ on CV-morbidity has to be confirmed in future clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Aart C. Strang, Radjesh J. Bisoendial, Ruud S. Kootte, Dominik M. Schulte, Geesje M. Dallinga-Thie, Johannes H.M. Levels, Marc Kok, Koen Vos, Sander W. Tas, Uwe J.F. Tietge, Nike Müller, Matthias Laudes, Danielle M. Gerlag, Erik S.G. Stroes,